50 related articles for article (PubMed ID: 11808937)
1. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
[TBL] [Abstract][Full Text] [Related]
2. Secondary Iron Overload and the Liver: A Comprehensive Review.
Pinyopornpanish K; Tantiworawit A; Leerapun A; Soontornpun A; Thongsawat S
J Clin Transl Hepatol; 2023 Aug; 11(4):932-941. PubMed ID: 37408825
[TBL] [Abstract][Full Text] [Related]
3. Iron as a therapeutic target in chronic liver disease.
Kouroumalis E; Tsomidis I; Voumvouraki A
World J Gastroenterol; 2023 Jan; 29(4):616-655. PubMed ID: 36742167
[TBL] [Abstract][Full Text] [Related]
4. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus.
Gupta S; Read SA; Shackel NA; Hebbard L; George J; Ahlenstiel G
Cells; 2019 Jun; 8(6):. PubMed ID: 31212984
[TBL] [Abstract][Full Text] [Related]
5. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.
Vela D
Mol Med; 2018 Mar; 24(1):5. PubMed ID: 30134796
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Uchino K; Tateishi R; Nakagomi R; Fujiwara N; Minami T; Sato M; Enooku K; Nakagawa H; Asaoka Y; Kondo Y; Shibahara J; Shiina S; Koike K
PLoS One; 2018; 13(7):e0200943. PubMed ID: 30044835
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Nutrition for Development (BOND)-Iron Review.
Lynch S; Pfeiffer CM; Georgieff MK; Brittenham G; Fairweather-Tait S; Hurrell RF; McArdle HJ; Raiten DJ
J Nutr; 2018 Jun; 148(suppl_1):1001S-1067S. PubMed ID: 29878148
[TBL] [Abstract][Full Text] [Related]
8. Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats.
Ohara Y; Chew SH; Shibata T; Okazaki Y; Yamashita K; Toyokuni S
Cancer Sci; 2018 Feb; 109(2):330-339. PubMed ID: 29193587
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based clinical practice guidelines for liver cirrhosis 2015.
Fukui H; Saito H; Ueno Y; Uto H; Obara K; Sakaida I; Shibuya A; Seike M; Nagoshi S; Segawa M; Tsubouchi H; Moriwaki H; Kato A; Hashimoto E; Michitaka K; Murawaki T; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Jul; 51(7):629-50. PubMed ID: 27246107
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.
Choi J; Corder NL; Koduru B; Wang Y
Free Radic Biol Med; 2014 Jul; 72():267-84. PubMed ID: 24816297
[TBL] [Abstract][Full Text] [Related]
11. Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
Ikeda Y; Ozono I; Tajima S; Imao M; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
PLoS One; 2014; 9(2):e89355. PubMed ID: 24586712
[TBL] [Abstract][Full Text] [Related]
12. Nutrition therapy for liver diseases based on the status of nutritional intake.
Yasutake K; Kohjima M; Nakashima M; Kotoh K; Nakamuta M; Enjoji M
Gastroenterol Res Pract; 2012; 2012():859697. PubMed ID: 23197979
[TBL] [Abstract][Full Text] [Related]
13. Quantification of hepatic iron concentration in chronic viral hepatitis: usefulness of T2-weighted single-shot spin-echo echo-planar MR imaging.
Tonan T; Fujimoto K; Qayyum A; Kawaguchi T; Kawaguchi A; Nakashima O; Okuda K; Hayabuchi N; Sata M
PLoS One; 2012; 7(3):e33868. PubMed ID: 22439008
[TBL] [Abstract][Full Text] [Related]
14. Phlebotomy improves histology in chronic hepatitis C males with mild iron overload.
Sartori M; Andorno S; Rossini A; Boldorini R; Bozzola C; Carmagnola S; Del Piano M; Albano E
World J Gastroenterol; 2010 Feb; 16(5):596-602. PubMed ID: 20128028
[TBL] [Abstract][Full Text] [Related]
15. The role of iron in the pathophysiology and treatment of chronic hepatitis C.
Price L; Kowdley KV
Can J Gastroenterol; 2009 Dec; 23(12):822-8. PubMed ID: 20011735
[TBL] [Abstract][Full Text] [Related]
16. Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
Hou WH; Rossi L; Shan Y; Zheng JY; Lambrecht RW; Bonkovsky HL
World J Gastroenterol; 2009 Sep; 15(36):4499-510. PubMed ID: 19777608
[TBL] [Abstract][Full Text] [Related]
17. The effect of iron depletion on chronic hepatitis C virus infection.
Franchini M; Targher G; Capra F; Montagnana M; Lippi G
Hepatol Int; 2008 Sep; 2(3):335-40. PubMed ID: 19669262
[TBL] [Abstract][Full Text] [Related]
18. Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C.
Fujita N; Takei Y
J Gastroenterol; 2007 Nov; 42(11):923-6. PubMed ID: 18008038
[No Abstract] [Full Text] [Related]
19. Role of iron in hepatic fibrosis: one piece in the puzzle.
Philippe MA; Ruddell RG; Ramm GA
World J Gastroenterol; 2007 Sep; 13(35):4746-54. PubMed ID: 17729396
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease.
Peretz G; Link G; Pappo O; Bruck R; Ackerman Z
World J Gastroenterol; 2006 Jan; 12(2):240-5. PubMed ID: 16482624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
